RayKnowChina Research Map
Shortlist0

Blood disorders

Atypical haemolytic uraemic syndrome

非典型溶血性尿毒症综合征

An inherited form of haemolytic uraemic syndrome, linked to changes in complement genes, that often leads to kidney failure.

Definition adapted from MeSH (US National Library of Medicine)

hospitals in mainland China
31

with a paper from 2016–2025 or a registered study

cities
23

where those hospitals are

open trials in China
0

ClinicalTrials.gov, 13 Nov 2026

Mainland China accounts for 7% of the world's English-language research papers on atypical haemolytic uraemic syndrome, 2021–2025 (3% in 2016–2020), and 17% of the world's registered trials on it have a site in China.

Research activity in public records, not a rating of care and not medical advice. How the numbers are made

31 hospitals in 23 cities

Order: papers led on atypical haemolytic uraemic syndrome, 2021–2025, then A–Z. Research activity, not a rating of care.

A hospital is listed when it led at least 1 papers or 1 trial on atypical haemolytic uraemic syndrome, or was a site in 1 or more trials. “Papers led” counts English-language PubMed papers whose first or last author lists the hospital first. Hospitals not listed may also treat it. Definitions

A square is a city. Its size and number are hospitals listed for this disease, not the amount of research. Choose one to show that city in the hospital list and the trial list.

Cities with the most listed hospitals

  1. Beijing6
  2. Changsha2
  3. Nanchang2
  4. Shanghai2
  5. Changchun1
  6. Chengdu1
  7. Chongqing1
  8. Fuzhou1
  9. Guangzhou1
  10. Hangzhou1

Each opens atypical haemolytic uraemic syndrome in that city. 13 more cities are in the menu below.

  1. 2 papers led
    No open trial led
  2. 2 papers led
    No open trial led
  3. 2 papers led
    No open trial led
  4. 1 paper led
    No open trial led
  5. 1 paper led
    No open trial led
  6. 1 paper led
    No open trial led
  7. Chinese PLA General Hospital

    中国人民解放军总医院Beijing

    1 paper led
    No open trial led
  8. 1 paper led
    No open trial led
  9. 1 paper led
    No open trial led
  10. First Affiliated Hospital, Zhejiang University

    浙江大学医学院附属第一医院Hangzhou

    1 paper led
    No open trial led
  11. Nanfang Hospital

    南方医科大学南方医院Guangzhou

    1 paper led
    No open trial led
  12. 1 paper led
    No open trial led
  13. 1 paper led
    No open trial led
  14. Renji Hospital

    上海交通大学医学院附属仁济医院Shanghai

    1 paper led
    No open trial led
  15. 1 paper led
    No open trial led
  16. Second Xiangya Hospital

    中南大学湘雅二医院Changsha

    1 paper led
    No open trial led
  17. 1 paper led
    No open trial led
  18. 1 paper led
    No open trial led
  19. 1 paper led
    No open trial led
  20. 0 papers led
    No open trial led
  21. 0 papers led
    No open trial led
  22. 0 papers led
    No open trial led
  23. 0 papers led
    No open trial led
  24. 0 papers led
    No open trial led
  25. Chidren's Hospital

    首都医科大学附属首都儿童医学中心Beijing

    0 papers led
    No open trial led
  26. 0 papers led
    No open trial led
  27. Jinling Hospital

    东部战区总医院(金陵医院)Nanjing

    0 papers led
    No open trial led
  28. 0 papers led
    No open trial led
  29. Shengjing Hospital of China Medical University

    中国医科大学附属盛京医院Shenyang

    0 papers led
    No open trial led
  30. Southwest Hospital, Army Medical University

    陆军军医大学第一附属医院(西南医院)Chongqing

    0 papers led
    No open trial led
  31. Xiangya Hospital

    中南大学湘雅医院Changsha

    0 papers led
    No open trial led

By university or health system 4

Hospitals carrying a university’s name, added together, plus papers that name only the university. Same order as above.

  1. Peking University Health Science Center

    北京大学医学部Beijing

    3 papers led
    2 hospitals
  2. Capital Medical University

    首都医科大学Beijing

    2 papers led
    1 hospital
  3. Jilin University

    吉林大学Changchun

    2 papers led
    1 hospital
  4. Nanchang University

    南昌大学Nanchang

    2 papers led
    2 hospitals

0

open trials on atypical haemolytic uraemic syndrome in China

Recruiting, not yet recruiting, or by invitation, as registered on ClinicalTrials.gov on 13 Nov 2026, with at least one listed hospital as lead sponsor or site, and at least one listed hospital's site marked open. Check the registry for the current status. Whether someone can take part is decided by the study team.

Trials registered only in China’s own registry (ChiCTR) are not included. Questions to check before asking about a trial

Search ClinicalTrials.gov for atypical haemolytic uraemic syndrome

Where these numbers come from

Papers

27 English-language PubMed papers on atypical haemolytic uraemic syndrome with an author in mainland China, 2021–2025; a hospital led a paper when its first or last author lists it first. Run the PubMed search

Trials

ClinicalTrials.gov records with a listed hospital as lead sponsor or site, as of 13 Nov 2026. ChiCTR is not included. Search ClinicalTrials.gov

Locations

Locations are shown at city centres. Check the hospital’s website for its address.

Suggest a correctionDownload the data (CSV)Definitions